CD8A and neoplasm: The single-gene biomarker BTLA has potential clinical significance and transformability like PD-L1.In addition, a greater increase in CD8+ T cells in serial tumor samples during therapy correlated with a greater tumor-size decrease in imaging (Spearman’s correlation coefficient = −0.75; p = 0.0002) (60).